Sichenzia Ross Friedman Ference LLP Represents BioPharmX Corporation in $930,000 Registered Direct Offering
Press Release – New York, NY – September 29, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented BioPharmX Corporation (NYSE. MKT “ BPMX) in a Registered Direct public offering of 1,550,000 registered shares of its common stock at a price of $.60 per share and 1,240,000 unregistered warrants to purchase common stock at an exercise price of $.75 per share for gross proceeds to BPMX of $930,000. Rodman & Renshaw a Unit of H.C. Wainwright & Co., LLC acted as the exclusive Placement Agent for the offering. The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe and Counsel Jeff Cahlon.
- Glenn Burlingame - July 8, 2021
- Sichenzia Ross Ference LLP 在纽约证券交易所收盘敲钟仪式上祝贺并加入 KULR Technology Group Inc. - July 7, 2021
- Sichenzia Ross Ference LLP 代表 Document Security Systems, Inc. 完成 5,000 万美元的普通股公开发售，包括行使超额配售权 - June 22, 2021